慢性阻塞性肺病患者血液中的单细胞转录组
Yeonjeong Heo1, Jeeyoung Kim1, Seok-Ho Hong2
1Department of Internal Medicine, Kangwon National University Hospital, Chuncheon, Korea.
BMC pulmonary medicine
|January 14, 2025
概括
单细胞RNA测序揭示了明显的细胞类型分布,特别是在慢性阻塞性肺病 (COPD) 患者的单细胞/巨细胞中. 这项研究确定了这些细胞中的特定基因表达变化,为COPD病变产生提供了新的见解.
科学领域:
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 肺部病理学 肺部病理学
背景情况:
- 慢性阻塞性肺病 (COPD) 是全球重要的健康负担.
- 单细胞RNA测序 (scRNA-seq) 提供了高分辨率的基因表达分析.
- 了解COPD的外周血液细胞变化至关重要.
研究的目的:
- 用scRNA-seq.来评估COPD患者外周血液中的基因表达特征.
- 为了确定COPD患者和健康对照之间的细胞类型分布和基因表达的差异.
- 探索潜在的COPD背后的分子机制.
主要方法:
- 从健康对照组 (n=7) 和COPD患者 (n=8) 收集了周围血液样本.
- scRNA-seq是使用10X Genomics Chromium平台进行的.
- 使用计算分析,基因本体学和KEGG通路分析来比较基因表达.
主要成果:
- 在COPD组中观察到单细胞/巨细胞的比例增加.
- 与对照组相比,15个基因在COPD患者的单细胞/巨细胞中被上调,7个基因被下调.
- 具体的差异表达基因包括EGR1,NR4A1,CCL3和FOLR3,HLA-DRB5.5等.
结论:
- 在COPD中,scRNA-seq发现了周围血液细胞组成的显著差异,特别是单细胞/巨细胞.
- 单细胞/巨细胞中基因上调和下调的明显模式与COPD有关.
- 这些发现有助于理解COPD的细胞和分子格局.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


